Incyte told JP Morgan attendees of plans for four launches in 2025, beginning with its FDA-approved Niktimvo for chronic GVHD.

Eli Lilly’s CEO Dave Ricks cited stocking levels and unexpected market dynamics in Q4 2024 in the GLP-1RA market.

U.S. stocks added to gains following the data release, with futures contracts tied to the S&P 500 suggesting an 82 point ...

Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms through the next-gen sequencing ...

Dow Jones futures rose modestly Wednesday, along with S&P 500 futures and Nasdaq futures. The consumer price index is due ...

NFL draft order is rounding into shape with the wild card playoffs over. Here's our latest predictions led by Miami QB Cam ...

Wall Street saw a modest uptick on Tuesday as investors turned their focus to upcoming US inflation data following a ...

Relive Mail Sport live blog for the latest live score, team news and updates as Nottingham Forest host Liverpool at the City ...

"It's great to be in Connellsville," Nate Morgan told those attending the ribbon-cutting ceremony Tuesday for The River's ...

The remains had been stored at the University of Pennsylvania Museum of Archaeology and Anthropology for more than a century.

LOS ANGELES (AP) — Millions of Southern Californians were on edge as a final round of dangerous fire weather was forecast for ...

Global stocks edged up on Wednesday in cautious trading ahead of U.S. consumer price data that could shift the monetary ...